ProfileGDS4132 / 220240_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 34% 42% 34% 32% 32% 38% 33% 35% 39% 39% 43% 44% 41% 34% 37% 45% 37% 52% 45% 37% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10186.780534
GSM201543Muscle PCOS pioglitazone 121100.8442
GSM201544Muscle PCOS pioglitazone 16186.877234
GSM201545Muscle PCOS pioglitazone 20185.954232
GSM201829Muscle PCOS pioglitazone 23184.840632
GSM201830Muscle PCOS pioglitazon 251102.01538
GSM201831Muscle PCOS pioglitazone 27180.506733
GSM201832Muscle PCOS pioglitazone 3188.921635
GSM201833Muscle PCOS pioglitazone 4193.591939
GSM201834Muscle PCOS pioglitazone 8197.778639
GSM201835Muscle PCOS after pioglitazone 10298.14943
GSM201836Muscle PCOS after pioglitazone 122103.2844
GSM201837Muscle PCOS after pioglitazone 16289.316141
GSM201838Muscle PCOS after pioglitazone 20277.632634
GSM201839Muscle PCOS after pioglitazone 23288.322437
GSM201840Muscle PCOS after pioglitazone 252115.42145
GSM201841Muscle PCOS after pioglitazone 27279.948537
GSM201842Muscle PCOS after pioglitazone 32118.08852
GSM201843Muscle PCOS after pioglitazone 42114.72245
GSM201844Muscle PCOS after pioglitazone 8290.527237